-
J.-M. Combette
ribOvax Biotechnologies S.A., Petit Lancy, Switzerland
-
M. Berdugo
INSERM U598, Centre de recherche des Cordeliers, Paris, France
-
P. P. Sanna
The Scripps Research Institute, La Jolla, California
-
C. Abadie
ribOvax Biotechnologies S.A., Petit Lancy, Switzerland
-
Z. Chen
Calmune Corporation, San Diego, California
-
R. A. Williamson
Calmune Corporation, San Diego, California
-
J. M. Jeanny
INSERM U598, Centre de recherche des Cordeliers, Paris, France
-
C. Stella-Deutsch
School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland
-
R. Gurny
School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland
-
F. Behar-Cohen
INSERM U598, Centre de recherche des Cordeliers, Paris, France